electroCore

electroCore

Health Care Equipment & Supplies
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

$91.4M

Market Cap • 10/2/2026

2005

(21 years)

Founded

2018

(8 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

—

P/S

2,5

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

—

EPS

—

Market Cap

Market Cap

91,4M

EV

90,9M

EV/Revenue

2,5

EV/EBITDA

-6,7

EV/EBIT

-6,5

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-5,7%

Total Yield

-5,7%

Payout

0%

Retained Earnings

-199,4M

Profitability

Gross Margin

87,1%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

8,5%

Capex/Revenue

0%

Capex/D&A

4%

Capex/OCF

-0,1%

SBC/OCF

—

% PPE

16,9%

% Goodwill

0%

ROE

1761,5%

ROIC

—

Growth

CAGR Revenue 5Y

52,5%

CAGR Op. Income 5Y

-8,2%

CAGR Net Income 5Y

-5%

CAGR EPS 5Y

-23%

CAGR OCF 5Y

-8%

Leverage

N.D./EBITDA

0

Debt/Equity

0%

Current Ratio

1,2

Quick Ratio

0,9

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium